التفاصيل البيبلوغرافية
| العنوان: |
Fascia iliaca compartment block for postoperative pain after total hip arthroplasty: a systematic review and meta-analysis of randomized controlled trials. |
| المؤلفون: |
Eshag, Mona Muhe Eldeen, Hasan, Lina Omar Mahmoud, Elshenawy, Salem, Ahmed, Mennatallah Samir, Emad Mostafa, Abd El-moneam, Abdelghafar, Yomna Ali, Althawadi, Yusuf Jasim, Ibraheem, Najwa Medhat, Badr, Helmy, AbdelQadir, Yossef Hassan |
| المصدر: |
BMC Anesthesiology; 3/9/2024, Vol. 24 Issue 1, p1-11, 11p |
| مصطلحات موضوعية: |
MEDICAL information storage & retrieval systems, PAIN measurement, TOTAL hip replacement, POSTOPERATIVE pain, TREATMENT effectiveness, META-analysis, SURGICAL complications, SYSTEMATIC reviews, MEDLINE, ODDS ratio, PAIN management, OPIOID analgesics, MEDICAL databases, ONLINE information services, CONFIDENCE intervals, NERVE block |
| مستخلص: |
Background: Fascia iliaca compartment block (FICB) is one of the regional nerve blocks used to reduce pain after total hip arthroplasty (THA). We aim to assess the efficacy of FICB in reducing post-operative pain and opioid consumption. Methods: We searched PubMed, Web of Science, Cochrane Library, Embase, and Scopus on February 19, 2023, and we updated our search in august 2023 using relevant search strategy. Studies were extensively screened for eligibility by title and abstract screening, followed by full-text screening. We extracted the data from the included studies, and then pooled the data as mean difference (MD) or odds ratio (OR) with a 95% confidence interval (CI), using Review Manager Software (ver. 3.5). Results: FIBC significantly reduced analgesic consumption at 24 h (MD = -8.75, 95% CI [-9.62, -7.88] P < 0.00001), and at 48 h post-operatively. (MD = -15.51, 95% CI [-26.45, -4.57], P = 0.005), with a significant sensory block of the femoral nerve (P = 0.0004), obturator nerve (P = 0.0009), and lateral femoral cutaneous nerve (P = 0.002). However, FICB was not associated with a significant pain relief at 6, 24, and 48 h postoperatively, except at 12 h where it significantly reduced pain intensity (MD = -0.49, 95% CI [-0.85, -0.12], P = 0.008). FICB was also not effective in reducing post-operative nausea and vomiting (MD = 0.55, 95% CI [0.21, 1.45], P = 0.23), and was associated with high rates of quadriceps muscle weakness (OR = 9.09, % CI [3.70, 22.30], P = < 0.00001). Conclusions: FICB significantly reduces the total analgesic consumption up to 48 h; however, it is not effective in reducing post-operative pain, nausea and vomiting and it induced postoperative muscle weakness. [ABSTRACT FROM AUTHOR] |
|
Copyright of BMC Anesthesiology is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder